Piedmont Investment Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-14,908
| Closed | -$759K | – | 208 |
|
2020
Q1 | $759K | Buy |
14,908
+782
| +6% | +$39.8K | 0.03% | 347 |
|
2019
Q4 | $778K | Sell |
14,126
-1,759
| -11% | -$96.9K | 0.03% | 391 |
|
2019
Q3 | $800K | Sell |
15,885
-651
| -4% | -$32.8K | 0.03% | 375 |
|
2019
Q2 | $834K | Buy |
16,536
+4,245
| +35% | +$214K | 0.03% | 372 |
|
2019
Q1 | $571K | Buy |
12,291
+45
| +0.4% | +$2.09K | 0.02% | 468 |
|
2018
Q4 | $601K | Buy |
12,246
+3,297
| +37% | +$162K | 0.03% | 400 |
|
2018
Q3 | $555K | Sell |
8,949
-16,969
| -65% | -$1.05M | 0.02% | 474 |
|
2018
Q2 | $1.4M | Sell |
25,918
-15,988
| -38% | -$861K | 0.07% | 273 |
|
2018
Q1 | $1.91M | Hold |
41,906
| – | – | 0.05% | 265 |
|
2017
Q4 | $1.65M | Hold |
41,906
| – | – | 0.03% | 269 |
|
2017
Q3 | $1.55M | Sell |
41,906
-18,211
| -30% | -$671K | 0.03% | 266 |
|
2017
Q2 | $2.32M | Buy |
60,117
+23,376
| +64% | +$900K | 0.05% | 251 |
|
2017
Q1 | $1.25M | Buy |
36,741
+20,847
| +131% | +$710K | 0.03% | 300 |
|
2016
Q4 | $521K | Hold |
15,894
| – | – | 0.01% | 320 |
|
2016
Q3 | $513K | Buy |
15,894
+15,839
| +28,798% | +$511K | 0.01% | 310 |
|
2016
Q2 | $1.71K | Hold |
55
| – | – | ﹤0.01% | 339 |
|
2016
Q1 | $1.66K | Hold |
55
| – | – | ﹤0.01% | 345 |
|
2015
Q4 | $1.53K | Hold |
55
| – | – | ﹤0.01% | 361 |
|
2015
Q3 | $1.69K | Hold |
55
| – | – | ﹤0.01% | 352 |
|
2015
Q2 | $2.03K | Hold |
55
| – | – | ﹤0.01% | 343 |
|
2015
Q1 | $1.95K | Sell |
55
-7
| -11% | -$248 | ﹤0.01% | 263 |
|
2014
Q4 | $1.88K | Hold |
62
| – | – | ﹤0.01% | 267 |
|
2014
Q3 | $1.81K | Sell |
62
-91
| -59% | -$2.65K | ﹤0.01% | 263 |
|
2014
Q2 | $4.38K | Hold |
153
| – | – | ﹤0.01% | 225 |
|
2014
Q1 | $4.38K | Hold |
153
| – | – | ﹤0.01% | 221 |
|
2013
Q4 | $4.07K | Hold |
153
| – | – | ﹤0.01% | 219 |
|
2013
Q3 | $4.21K | Sell |
153
-2
| -1% | -$55 | ﹤0.01% | 198 |
|
2013
Q2 | $3.54K | Buy |
+155
| New | +$3.54K | ﹤0.01% | 264 |
|